We fused the epitope-recognizing fragment of heavy-chain antibodies from Camelidae sp. with fluorescent proteins to generate fluorescent, antigen-binding nanobodies (chromobodies) that can be expressed in living cells. We demonstrate that chromobodies can recognize and trace antigens in different subcellular compartments throughout S phase and mitosis. Chromobodies should enable new functional studies, as potentially any antigenic structure can be targeted and traced in living cells in this fashion.

Nanobodies are the smallest fragments of naturally occurring singledomain antibodies that have evolved to be fully functional in the absence of a light chain. Nanobodies are strictly monomeric, very stable, and highly soluble entities. We identified a nanobody with subnanomolar affinity for the human tumor-associated carcinoembryonic antigen. This nanobody was conjugated to Enterobacter cloacae ␤-lactamase, and its site-selective anticancer prodrug activation capacity was evaluated. The conjugate was readily purified in high yields without aggregation or loss of functionality of the constituents. In vitro experiments showed that the nanobody-enzyme conjugate effectively activated the release of phenylenediamine mustard from the cephalosporin nitrogen mustard prodrug 7-(4-carboxybutanamido) cephalosporin mustard at the surface of carcinoembryonic antigen-expressing LS174T cancer cells. In vivo studies demonstrated that the conjugate had an excellent biodistribution profile and induced regressions and cures of established tumor xenografts. The easy generation and manufacturing yield of nanobody-based conjugates together with their potent antitumor activity make nanobodies promising vehicles for new generation cancer therapeutics.

We report a microcantilever-based immunosensor operated in static deflection mode with a performance comparable with surface plasmon resonance, using single-chain Fv (scFv) antibody fragments as receptor molecules. As a model system scFv fragments with specificity to two different antigens were applied. We introduced a cysteine residue at the C terminus of each scFv construct to allow covalent attachment to gold-coated sensor interfaces in directed orientation. Application of an array enabled simultaneous deflection measurements of sensing and reference cantilevers. The differential deflection signal revealed specific antigen binding and was proportional to the antigen concentration in solution. Using small, oriented scFv fragments as receptor molecules we increased the sensitivity of microcantilevers to Ϸ1 nM.cantilever arrays ͉ nanomechanics ͉ proteomics M icrocantilever-based sensors have attracted much interest as devices for fast and reliable detection of small amounts of molecules in air and solution. Over the last few years the application of the cantilever sensor concept was extended to the measurements of biocompounds in solution, resulting in a versatile biosensor (1, 2). Because of its label-free detection principle and small size, this kind of biosensor is advantageous for diagnostic applications, disease monitoring, and research in genomics or proteomics (3, 4). Multicantilever arrays would enable the detection of several analytes simultaneously.The main principle of the cantilever static mode is the transduction of the molecular interaction between analyte and receptors, immobilized as a layer on one surface of a cantilever, into a nanomechanical motion of the cantilever. Biomolecular interactions taking place on a solid-state interface produce a change in surface stress, because of changes in molecular configuration and intermolecular crowding (5). This process results in bending of the cantilever. Microcantilever-based biosensors operated in static mode have been successfully applied for the detection of various molecular interactions such as ssDNA-ssDNA (5-7) or protein-DNA (8, 9). Interactions between proteins were detected with cantilever-based immunosensors, where an antigen was recognized by its cognate antibody randomly immobilized on the sensor surface (10-12).The most critical step in preparation of any immunosensor is the immobilization of capture molecules on the support, a process where the orientation of the antigen-binding sites toward the analyte in solution plays a key role. Immunoglobulins can be either adsorbed on gold directly (10, 12) or attached covalently to the surface modified with hetero-bifunctional self-assembled monolayers of alkylthiols (11). However, these approaches produce a layer of randomly oriented antibody molecules on the cantilever surface, thereby generating conformational heterogeneity and inactive receptor molecules (13,14).As previously shown (13,(15)(16)(17)(18), the sensitivity of immunosensors can be improved by both maximizing the degree of functional ...